← Back to Balaxi Pharmaceuticals Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

BALAXIPharmaceuticals

Balaxi Pharmaceuticals Ltd — Financial Ratios & Key Metrics

₹15.67

-9.20%

P/E Ratio13.86xIndustry: 31.77x

ROE11.61%Return on equity

ROCE12.95%Return on capital

Debt/Equity0.24Low debt

💎

Valuation & Profitability

P/E Ratio

13.86x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹200.96 (Cr)

Sales Growth 5Y

45.01%

Profit Growth 5Y

32.75%

EPS Growth 5Y

30.15%

OPM 5Y Avg

16.50%

📉

Price Returns

1 Month

-15.23%

3 Months

-20.54%

6 Months

-28.60%

1 Year

-55.69%

52W Low

₹15

Current

₹16

52W High

₹74

1% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹21

▼ Price below SMA 50 — Bearish

SMA 200

₹37

▼ Long-term downtrend

Volume Signal

103% of avg

Average volume

Technical indicators are for educational purposes only. Not investment advice.

More on Balaxi Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.